University of Louisville: Lung Neoplasms trials

The registry lists 11 Lung Neoplasms studies with University of Louisville as lead sponsor. 2 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung CancersRecruitingNCT01871454Phase 2
• The Effect of Beta-glucan in Non-Small Cell Lung CancerRecruitingNCT00682032Not applicable
• Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung CancerTerminatedNCT00281021Phase 2Results posted
• Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung CancerTerminatedNCT00265200Phase 2Results posted
• A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung CancerStatus unknownNCT01500876Not applicable
• Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung CancerTerminatedNCT01426620Phase 2
• STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)WithdrawnNCT01300299Not applicable
• The Effect of Berries on Lung Cancer TumorsTerminatedNCT00681512Not applicable
• Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced AnemiaWithdrawnNCT00481624Phase 2
• Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerTerminatedNCT00268151Phase 1
• Metabolomic Analysis of Lung CancerCompletedNCT00263731